Each of us caresabout someone🔒 SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for abcellera.com. This domain is officially recognized as AbCellera. According to their official web presence, their primary focus is: "We are advancing differentiated antibody drug programs with first-in-class and best-in-class potential across multiple indications and modalities.".
Table of Contents
- ↓ Our pipeline.
- ↓ From target to the clinic. Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
- ↓ Peopleconnected.
- ↓ Withpurpose.
- ↓ Tiffany Mintah
- ↓ AbCellera’s commitment to people, teams, and relationships is what drew me towards the company. I’m surrounded by brilliant, kind, and down-to-earth people every day, and I’m excited to contribute to this team.
- ↓ Top Alternatives to abcellera.com
- Tech Stack
- Cloudflare
- Link Profile
- Internal Pages: 56Outbound Links: 4
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$468,949
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- abcellera.comTaken
- abcellera.netTaken
- abcellera.orgTaken
- abcellera.ioAvailable
- abcellera.coAvailable
- abcellera.aiAvailable
Official Contact & Profiles
Socials:ca.linkedin.comtwitter.com
Content Snippets from abcellera.com
"ABCL635 is an investigational antibody drug candidate being developed for the non-hormonal treatment of VMS (commonly known as hot flashes) due to adjuvant endocrine therapy (AET) for breast cancer. ABCL635 specifically targets NK3R, a complex transmembrane protein found on hypothalamic KNDy neurons that helps regulate body temperature."
"ABCL635 is also being developed for the treatment of VMS due to menopause and VMS due to androgen deprivation therapy (ADT) for prostate cancer."
"ABCL635 is an investigational antibody drug candidate being developed for the non-hormonal treatment of VMS (commonly known as hot flashes) due to androgen deprivation therapy (ADT) for prostate cancer. ABCL635 specifically targets NK3R, a complex transmembrane protein found on hypothalamic KNDy neurons that helps regulate body temperature."
"ABCL635 is also being developed for the treatment of VMS due to menopause and VMS due to adjuvant endocrine therapy (AET) for breast cancer."
Key Topics & Focus Areas for abcellera.com:
Our pipeline.
From target to the clinic. Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
Peopleconnected.
Withpurpose.
Tiffany Mintah
AbCellera’s commitment to people, teams, and relationships is what drew me towards the company. I’m surrounded by brilliant, kind, and down-to-earth people every day, and I’m excited to contribute to this team.
By comparing abcellera.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to abcellera.com.
Frequently Asked Questions
Is abcellera.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of abcellera.com?
As of November 15, 2026, abcellera.com holds an estimated domain authority score of 83/100 based on our VisitRank tracking algorithms.
What are the top alternatives to abcellera.com?
You can find the best alternatives and similar sites to abcellera.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for abcellera.com:
acbellera.comabellera.comabbcellera.comebcellera.comabcallera.comabcellara.comabcellere.comavcellera.comagcellera.com